BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21387134)

  • 1. Clinical outcome and management of ureteral obstruction secondary to gastric cancer.
    Migita K; Watanabe A; Samma S; Ohyama T; Ishikawa H; Kagebayashi Y
    World J Surg; 2011 May; 35(5):1035-41. PubMed ID: 21387134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
    Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
    J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of ureteral obstruction in primary cervical cancer.
    Lee SK; Jones HW
    Int J Gynaecol Obstet; 1994 Jan; 44(1):59-65. PubMed ID: 7907060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcomes After Urinary Diversion for Malignant Ureteral Obstruction Secondary to Non-urologic Cancer: An Analysis of 778 Cases.
    Heo JE; Jeon DY; Lee J; Ham WS; Choi YD; Jang WS
    Ann Surg Oncol; 2021 Apr; 28(4):2367-2373. PubMed ID: 33389298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of palliative urinary diversion in the treatment of advanced malignancies.
    Shekarriz B; Shekarriz H; Upadhyay J; Banerjee M; Becker H; Pontes JE; Wood DP
    Cancer; 1999 Feb; 85(4):998-1003. PubMed ID: 10091780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative percutaneous and endoscopic urinary diversion for malignant ureteral obstruction.
    Gasparini M; Carroll P; Stoller M
    Urology; 1991 Nov; 38(5):408-12. PubMed ID: 1719688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimally invasive management of acute ureteral obstruction and severe infection caused by upper urinary tract calculi.
    Zhang Z; Wang X; Chen D; Peng N; Chen J; Wang Q; Yang M; Zhang Y
    J Xray Sci Technol; 2020; 28(1):125-135. PubMed ID: 31796723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of extrinsic malignant ureteral obstruction with urinary diversion.
    Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
    Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients.
    Cordeiro MD; Coelho RF; Chade DC; Pessoa RR; Chaib MS; Colombo-Júnior JR; Pontes-Júnior J; Guglielmetti GB; Srougi M
    BJU Int; 2016 Feb; 117(2):266-71. PubMed ID: 25327474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies.
    Barton DP; Morse SS; Fiorica JV; Hoffman MS; Roberts WS; Cavanagh D
    Obstet Gynecol; 1992 Nov; 80(5):805-11. PubMed ID: 1407920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous nephrostomy in the management of malignant ureteral obstruction secondary to bladder cancer.
    Ekici S; Sahin A; Ozen H
    J Endourol; 2001 Oct; 15(8):827-9. PubMed ID: 11724123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of Palliative Urinary Diversion and Observation for Malignant Extrinsic Ureteral Obstruction.
    Tatenuma T; Tsutsumi S; Yasui M; Noguchi G; Umemoto S; Kishida T
    J Palliat Med; 2020 Feb; 23(2):254-258. PubMed ID: 31834827
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical evaluation of ureteral stenting for managing extrinsic ureteral obstruction due to gynecological and gastrointestinal cancer].
    Takehara K; Onita T; Mochizuki Y; Miyata Y; Igawa T; Sakai H
    Hinyokika Kiyo; 2014 Jan; 60(1):13-6. PubMed ID: 24594767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ureteral obstruction associated with prostate cancer: the outcome after percutaneous nephrostomy.
    Chiou RK; Chang WY; Horan JJ
    J Urol; 1990 May; 143(5):957-9. PubMed ID: 2329611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonoperative urinary diversion for malignant ureteral obstruction.
    Zadra JA; Jewett MA; Keresteci AG; Rankin JT; St Louis E; Grey RR; Pereira JJ
    Cancer; 1987 Sep; 60(6):1353-7. PubMed ID: 3621117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal function is associated with prognosis in stent-change therapy for malignant ureteral obstruction.
    Yoon JH; Park S; Park S; Moon KH; Cheon SH; Kwon T
    Investig Clin Urol; 2018 Nov; 59(6):376-382. PubMed ID: 30402570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Affecting Survival Outcome After Percutaneous Nephrostomy as Palliative Urinary Diversion in Obstructive Uropathy due to Advance Cervical Cancer Patients.
    Noegroho BS; Kurniawan AP; Wijayanti Z; Mustafa A
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):1211-1216. PubMed ID: 33906314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of ureteral obstruction due to advanced malignancy: optimizing therapeutic and palliative outcomes.
    Kouba E; Wallen EM; Pruthi RS
    J Urol; 2008 Aug; 180(2):444-50. PubMed ID: 18550089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival Outcome of Urinary Diversion in Advanced Cervical Cancer Patients with Hydronephrosis.
    Dhani FK; Daryanto B; Seputra KP
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2641-2646. PubMed ID: 37642049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of ureterocystoneostomy for inner urinary diversion in locally advanced prostate carcinoma].
    Wawroschek F; Hamm M; Rathert P
    Urologe A; 1998 Jul; 37(4):372-6. PubMed ID: 9738288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.